Genmab A/S
GMAB· Nasdaq
GMABGenmab A/S
Quarterly figures for Genmab A/S, with source filings when available.
2 quarters. Jun 30, 2024 to Jun 30, 2025. USD.
Filing lag not yet established. Fewer than two comparable filings are on file.
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | |||||||||
| Q2 2025 | Jun 30, 2025 | — | — | — | — | ||||
Genmab A/S · CIK 1434265 · Engraved from SEC EDGAR
| $925.00M |
| +18.7% |
| $5.42 |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q2 2024 | Jun 30, 2024 | — | — | — | — | $779.00M | — | $3.13 | |
